![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1300, 2010-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety updates from EMA's CHMP
Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CHMP opinions on safety variations
Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CHMP's latest opinions on drug safety labelling
Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New Avastin safety info issued in Canada
Reactions Weekly, Vol. 1, Iss. 1157, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. :